miR‐345‐5p regulates proliferation, cell cycle, and apoptosis of acute myeloid leukemia cells by targeting AKT2
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR‐345‐5p regulates proliferation, cell cycle, and apoptosis of acute myeloid leukemia cells by targeting AKT2
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 120, Issue 2, Pages 1620-1629
Publisher
Wiley
Online
2018-10-03
DOI
10.1002/jcb.27461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML
- (2018) Lauren Herschbein et al. BLOOD REVIEWS
- Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia
- (2017) Yoko Tabe et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia
- (2017) Emilia L. Lim et al. JOURNAL OF CLINICAL ONCOLOGY
- A tyrosine kinase-STAT5-miR21-PDCD4 regulatory axis in chronic and acute myeloid leukemia cells
- (2017) Anne-Sophie Espadinha et al. Oncotarget
- Hematopoietic Stem Cell Niche in Health and Disease
- (2016) Jonathan Hoggatt et al. Annual Review of Pathology-Mechanisms of Disease
- miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia
- (2016) Silvia Nucera et al. CANCER CELL
- Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
- (2015) Javid J. Moslehi et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Translational implications of somatic genomics in acute myeloid leukaemia
- (2014) Sara C Meyer et al. LANCET ONCOLOGY
- The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation
- (2013) Su Jung Song et al. Cell Stem Cell
- Retracted: Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL
- (2013) Xue Li et al. PEDIATRIC BLOOD & CANCER
- miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia
- (2013) P. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection
- (2012) J Peveling-Oberhag et al. LEUKEMIA
- Therapeutic Advances in Acute Myeloid Leukemia
- (2011) Alan Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting
- (2011) Marina Y. Konopleva et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNAs in Development and Disease
- (2011) Danish Sayed et al. PHYSIOLOGICAL REVIEWS
- Differential expression of specific microRNA and their targets in acute myeloid leukemia
- (2010) Giuseppe Cammarata et al. AMERICAN JOURNAL OF HEMATOLOGY
- The miR-17-92 microRNA Polycistron Regulates MLL Leukemia Stem Cell Potential by Modulating p21 Expression
- (2010) Piu Wong et al. CANCER RESEARCH
- Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States Medicare Beneficiaries
- (2010) Stuart L. Goldberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Insights in Chronic Lymphocytic Leukemia: Are We Getting Closer to Understanding the Pathogenesis of the Disease?
- (2008) Federico Caligaris-Cappio et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation
- (2008) Marina Bousquet et al. JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now